Essilor Strengthens US Prescription Laboratory Network
527313
CHARENTON-LE-PONT, France, June 20  /PRNewswire-FirstCall/ -- Essilor  of America, Essilor International's US subsidiary, has acquired a majority stake in Sutherlin Optical Company and purchased the assets of Dispensers Optical Service Corp.'s safety prescription division.
364598
Wal-Martâs expansion of its low-cost generic drug program indicates that the company is reaching out to a younger and broader clientÃ¨le.
150048
The Food and Drug Administration will establish a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they're on the market and update physicians and patients with emerging information on risks and benefits.
599353
A US group charged with helping to develop Medicare guidelines released a proposal on Thursday classifying medicines in groups that could determine how likely certain drugs would be covered under a new prescription drug benefit.
610018
New technology could lead to safer, more effective drugs.
240121
Drugmakers get part of the job done outside of the U.S.
119342
The Food and Drug Administration launched an effort this week to use radio frequency identification technology to track the nation&#39;s drug supply from manufacturer to pharmacy to reduce counterfeiting.
599733
The Food & Drug Administration has approved plans to begin testing of the Argus II, a next generation electronic retina, at the University of Southern california.
724815
Oct. 24 - Israeli company InSightec has announced that the US Food and Drug Administration (FDA) has awarded pre-market approval to the company&#39;s ExAblate 2000 system for non-invasive surgery for symptomatic uterine fibroids.
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
501038
Chemtura Corporation (NYSE:CEM) will increase capacity for epoxy plasticizers by 15% at its Taft, Louisiana manufacturing facility, beginning January 2007.
323837
Acting FDA commissioner, Dr. Lester Crawford, says he is satisfied that these additional activities will strengthen the FDA&#39;s program to greater ensure the safety of medical products that are making a major contribution to the health and quality of life
538105
Four months after an international panel of doctors recommended that the US Food and Drug Administration (FDA) approve InSightec&#39;s ExAblate 2000 for commercial use, the FDA announced on Friday that it had accepted the recommendation, and granted the
92270
The Food and Drug Administration yesterday unveiled a proposal designed to give thousands of seriously ill patients easier access to experimental treatments.
647664
A U.S. group charged with helping to develop Medicare guidelines released a proposal on Thursday classifying medicines in groups that could determine how likely certain drugs would be covered under a new prescription drug benefit.
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
31565
Hyperion Solutions, a vendor of business intelligence applications, will announce at its Solutions 2004 Hyperion International Conference in Paris this week, Essbase 7X, a greatly enhanced version of its analytic suite.